149 related articles for article (PubMed ID: 36156027)
1. [Issues of Equalization of Cancer Genomic Medicine-Focusing on the Current Status in Nagasaki Prefecture].
Ashizawa K; Udo E; Soda M; Furusato B
Gan To Kagaku Ryoho; 2022 Sep; 49(9):1005-1007. PubMed ID: 36156027
[TBL] [Abstract][Full Text] [Related]
2. [Panel Discussion - Problems in the Cancer Genomic Medicine].
Ishioka C; Muto M; Yachida S; Shirota H; Hirasawa A; Miyagawa K; Ashizawa K; Kinoshita I; Nishihara H; Matsuura N; Sakurai A
Gan To Kagaku Ryoho; 2022 Sep; 49(9):1014-1017. PubMed ID: 36156030
[TBL] [Abstract][Full Text] [Related]
3. [Preparation of the Cancer Genomic Medicine in the Tohoku District-Activity of Tohoku University Hospital as the Cancer Genome Medicine Core Base Hospital in Japan].
Ishioka C
Gan To Kagaku Ryoho; 2021 Jul; 48(7):878-881. PubMed ID: 34267020
[TBL] [Abstract][Full Text] [Related]
4. [Cooperative Tasks among Cancer Genome Medicine Facilities].
Shirota H
Gan To Kagaku Ryoho; 2022 Sep; 49(9):997-999. PubMed ID: 36156024
[TBL] [Abstract][Full Text] [Related]
5. [Development of Cancer Genomic Medicine in Kyushu Region and the Roles of Kyushu University Hospital as a Core Hospital for Cancer Genomic Medicine].
Ito M; Baba E
Gan To Kagaku Ryoho; 2021 Jul; 48(7):873-877. PubMed ID: 34267019
[TBL] [Abstract][Full Text] [Related]
6. [Multidisciplinary Collaboration and Education Program Required for Equalization of Cancer Genomic Medicine].
Miyagawa K
Gan To Kagaku Ryoho; 2022 Sep; 49(9):1002-1004. PubMed ID: 36156026
[TBL] [Abstract][Full Text] [Related]
7. [Expert Panel Issues in Japan].
Muto M
Gan To Kagaku Ryoho; 2022 Sep; 49(9):991-993. PubMed ID: 36156022
[TBL] [Abstract][Full Text] [Related]
8. [The Role of Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan].
Sunami K
Gan To Kagaku Ryoho; 2019 Apr; 46(4):617-621. PubMed ID: 31164495
[TBL] [Abstract][Full Text] [Related]
9. C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan.
Kohno T; Kato M; Kohsaka S; Sudo T; Tamai I; Shiraishi Y; Okuma Y; Ogasawara D; Suzuki T; Yoshida T; Mano H
Cancer Discov; 2022 Nov; 12(11):2509-2515. PubMed ID: 36321305
[TBL] [Abstract][Full Text] [Related]
10. [Additional Remarks on the Issue of Cancer Genomic Medicine-Regarding Regional Disparity and Exit Strategies].
Kinoshita I
Gan To Kagaku Ryoho; 2022 Sep; 49(9):1008-1010. PubMed ID: 36156028
[TBL] [Abstract][Full Text] [Related]
11. [The Roles of Designated Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan].
Nishida T
Gan To Kagaku Ryoho; 2018 Sep; 45(9):1223-1227. PubMed ID: 30237359
[TBL] [Abstract][Full Text] [Related]
12. [Interinstitutional Collaboration for Molecular Tumor Boards].
Komine K; Shirota H
Gan To Kagaku Ryoho; 2019 Apr; 46(4):626-629. PubMed ID: 31164497
[TBL] [Abstract][Full Text] [Related]
13. Human resources for administrative work to carry out a comprehensive genomic profiling test in Japan.
Kage H; Oda K; Muto M; Tsuchihara K; Okita N; Okuma Y; Kikuchi J; Shirota H; Hayashi H; Kokuryo T; Sakai D; Hirasawa A; Kubo M; Kenmotsu H; Akiyama N; Shinozaki-Ushiku A; Tanabe M; Ushiku T; Miyagawa K; Seto Y
Cancer Sci; 2023 Jul; 114(7):3041-3049. PubMed ID: 37165760
[TBL] [Abstract][Full Text] [Related]
14. Cancer genomic medicine in Japan and the roles of pharmacists.
Aomori T; Sakurai H; Nishihara H
Pharmacogenet Genomics; 2022 Aug; 32(6):242-245. PubMed ID: 35696282
[TBL] [Abstract][Full Text] [Related]
15. [Current Status and Future Direction of Cancer Genomic Medicine in Japan].
Muto M
Gan To Kagaku Ryoho; 2020 Feb; 47(2):197-202. PubMed ID: 32381946
[TBL] [Abstract][Full Text] [Related]
16. [From the Standpoint of a Core Center Hospital for Cancer Genome Medicine-Establishment of a Provision System for Wide-Area Precision Oncology].
Muto M; Kondo T; Yoshioka M; Fukuyama K; Suga J; Sato M; Masuda F; Ashida K; Mukai K; Matsumoto S; Kanai M
Gan To Kagaku Ryoho; 2021 Jul; 48(7):866-872. PubMed ID: 34267018
[TBL] [Abstract][Full Text] [Related]
17. Establishment and implementation of Cancer Genomic Medicine in Japan.
Mukai Y; Ueno H
Cancer Sci; 2021 Mar; 112(3):970-977. PubMed ID: 33289217
[TBL] [Abstract][Full Text] [Related]
18. [Development of an advanced education program for community medicine by Nagasaki pharmacy and nursing science union consortium].
Teshima M; Nakashima M; Hatakeyama S
Yakugaku Zasshi; 2012; 132(1):11-5. PubMed ID: 22214573
[TBL] [Abstract][Full Text] [Related]
19. Cancer genomic medicine in Japan.
Mano H
Proc Jpn Acad Ser B Phys Biol Sci; 2020; 96(7):316-321. PubMed ID: 32788553
[TBL] [Abstract][Full Text] [Related]
20. Patient survey on cancer genomic medicine in Japan under the national health insurance system.
Kage H; Akiyama N; Chang H; Shinozaki-Ushiku A; Ka M; Kawata J; Muto M; Okuma Y; Okita N; Tsuchihara K; Kikuchi J; Shirota H; Hayashi H; Kokuryo T; Yachida S; Hirasawa A; Kubo M; Kenmotsu H; Tanabe M; Ushiku T; Muto K; Seto Y; Oda K
Cancer Sci; 2024 Mar; 115(3):954-962. PubMed ID: 38273803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
